Shanghai Fosun Pharmaceutical | |
Stock Exchange | Other OTC |
EPS |
$0.16 |
Market Cap |
$7.87 B |
Shares Outstanding |
551.94 M |
Public Float |
- |
Shanghai Fosun Pharmaceutical | |
Stock Exchange | Hong Kong Stock Exchange |
EPS |
HKD1.26 |
Market Cap |
HKD61.77 B |
Shares Outstanding |
551.94 M |
Public Float |
520.66 M |
Shanghai Fosun Pharmaceutical | |
Stock Exchange | Shanghai Stock Exchange |
EPS |
CNY1.07 |
Market Cap |
CNY68.71 B |
Shares Outstanding |
1.91 B |
Public Float |
908.9 M |
Address |
Building A Shanghai Shanghai 200233 China |
Employees | - |
Website | http://www.fosunpharma.com |
Updated | 07/08/2019 |
Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. |